Patent ID: 8529492
Filing Date: 2013-09-10
Classification: A61F,A61K,A61M,A61P,Y02A

Abstract:
1. A method of treating an ocular disorder of an eye, comprising: forming a self-sealing incision in the cornea into the anterior chamber of the eye; introducing through the incision an implant comprising a proximal end with at least one inflow port, a distal end with at least one outflow port, and an interior volume extending through the implant between the at least one inflow port and at least one outflow port, wherein the implant is mounted on a delivery wire of an implantation instrument extending through the interior volume of the implant; passing the distal end and the proximal end of the implant through the anterior chamber; positioning the distal end of the implant between a first and second tissue layer and into fluid communication with the suprachoroidal space using the implantation instrument using the delivery wire on which the implant is mounted; flowing a drug-release material comprising at least one active agent through the delivery wire of the implantation instrument and the interior volume of the implant; hydrodissecting a space between the first and second tissue layers using the drug-release material flowed through the implant creating a lake of the drug-release material near the distal end of the implant in fluid communication with the suprachoroidal space; and eluting the at least one active agent from the drug-release material to treat the eye as the drug-release material degrades, wherein the space is maintained after the lake of drug-release material degrades.